T
AVNS icon

Transce3nd’s Avanos Medical AVNS Stock Holding History

Transce3nd’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11
Closed -$135 – 224
2025
Q2 		$135 Hold
11
– – ﹤0.01% 1177
2025
Q1 		$158 Hold
11
– – ﹤0.01% 1141
2024
Q4 		$175 Buy
+11
New +$218 ﹤0.01% 1477

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Transce3nd's AVNS Position: Q3 2025 in Review

Transce3nd sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 11 shares — an estimated $135 sold.

Transce3nd first reported a position in AVNS in Q4 2024 and held it in 3 quarters. The position peaked at $175 in Q4 2024. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Transce3nd reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Transce3nd sold 11 Avanos Medical shares in Q3 2025, an estimated $135.
  • Transce3nd first reported a position in Avanos Medical in Q4 2024 and held it in 3 quarters.
  • Transce3nd's Avanos Medical position peaked at $175 in Q4 2024.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.